Page 35 - Physical activity in recipients of solid organ transplantation - Edwin J. van Adrichem

References
Physical activity in recipients of solid organ transplantation
1. KDIGO clinical practice guideline for the care of kidney transplant recipients.
2. Oterdoom LH, de Vries AP, van Ree RM, Gansevoort RT, van Son WJ, van der Heide JJ et al. N-
3. Gillis KA, Patel RK, Jardine AG. Cardiovascular complications after transplantation: treatment
Adv Chronic Kidney Dis.
2006; 82(5):603-611.
2011; 6(4):898-905.
2004; 11(2):116-133.
Am J Transplant.
2009;
9 Suppl 3S1-155.
terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general
population.
Transplantation.
2009; 87(10):1562-1570.
options in solid organ recipients.
Transplant Rev (Orlando).
4. Foley RN. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
36 Suppl 14-8.
2014; 28(2):47-55.
J Ren Care.
2010;
5. Yeo FE, Villines TC, Bucci JR, Taylor AJ, Abbott KC. Cardiovascular risk in stage 4 and 5
nephropathy.
6. Ojo AO. Cardiovascular complications after renal transplantation and their prevention.
Transplantation.
7. Zelle DM, Corpeleijn E, Stolk RP, de Greef MH, Gans RO, van der Heide JJ et al. Low physical
activity and risk of cardiovascular and all-cause mortality in renal transplant recipients.
Clin J Am Soc
Nephrol.
8. van den Ham EC, Kooman JP, Schols AM, Nieman FH, Does JD, Franssen FM et al. Similarities in
skeletal muscle strength and exercise capacity between renal transplant and hemodialysis patients.
2005; 5(8):1957-1965.
Am J
Transplant.
9. Dontje ML, de Greef MH, Krijnen WP, Corpeleijn E, Kok T, Bakker SJ et al. Longitudinal
measurement of physical activity following kidney transplantation.
Clin Transplant.
2014; 28(4):
394-402.
10. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease.
Am Soc Nephrol.
1998; 9(12 Suppl):S16-23.
11. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Je
transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease.
ery J. Congestive heart failure in renal
J

J Am Soc
Nephrol.
2002; 13(4):1084-1090.
12. Lentine KL, Schnitzler MA, Abbott KC, Li L, Burroughs TE, Irish W et al. De novo congestive heart
failure after kidney transplantation: a common condition with poor prognostic implications.
Am J
Kidney Dis.
2005; 46(4):720-733.
13. Siedlecki A, Foushee M, Curtis JJ, Gaston RS, Perry G, Iskandrian AE et al.
ventricular systolic dysfunction on survival after renal transplantation.

Transplantation.
e impact of left
2007; 84(12):
1610-1617.
14. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al. 2016 ESC Guidelines for
the diagnosis and treatment of acute and chronic heart failure:
failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.

e Task Force for the diagnosis and
treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed
with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J.
2016;
37(27):2129-2200.
15. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB et al. National Academy of
Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and
utilization of biochemical markers in acute coronary syndromes.
Circulation.
2007; 115(13):e356-75.
16. Lainscak M, Haehling SV, Anker SD. Natriuretic peptides and other biomarkers in chronic heart
International
journal of cardiology.
y
gesen K, Alpert JS, Ja
2009;
17. Xu RY, Zhu XF, Yang Y, Ye P. High-sensitive cardiac troponin T.

e AS, Simoons ML, Chaitman BR, White HD et al.
J Geriatr Cardiol.
2013;

ird universal
de
nition of myocardial infarction.
Circulation.
2012; 126(16):2020-2035.
18.
33.
2